Search results for "Endocannabinoid system"

showing 10 items of 153 documents

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

2009

Both agonists (e.g. Delta(9)-tetrahydrocannabinol, nabilone) and antagonists (e.g. rimonabant, taranabant) of the cannabinoid type-1 (CB(1)) receptor have been explored as therapeutic agents in diverse fields of medicine such as pain management and obesity with associated metabolic dysregulation, respectively. CB(1) receptors are widely distributed in the central nervous system and are involved in the modulation of emotion, stress and habituation responses, behaviours that are thought to be dysregulated in human psychiatric disorders. Accordingly, CB(1) receptor activation may, in some cases, precipitate episodes of psychosis and panic, while its inhibition may lead to behaviours reminiscen…

PsychosisCannabinoid receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPharmacologyEndocrinologyTaranabantPiperidinesReceptor Cannabinoid CB1RimonabantCannabinoid Receptor ModulatorsmedicineAnimalsHumansDronabinolDepressive Disorderbusiness.industryCannabinoid Receptor Agonistsmedicine.diseaseAnxiety DisordersEndocannabinoid systemNabiloneAffectPyrazolesCannabinoidRimonabantbusinessNeurosciencemedicine.drugBest Practice & Research Clinical Endocrinology & Metabolism
researchProduct

Acetaldehyde, motivation and stress: Behavioral evidence of an addictive ménage à trois

2017

Acetaldehyde contributes to alcohol’s psychoactive effects through its own rewarding properties. Recent studies shed light on the behavioral correlates of acetaldehyde administration and the possible interactions with key neurotransmitters for motivation, reward and stress-related response, such as dopamine and endocannabinoids. This mini review critically examines acetaldehyde psychoactive properties, focusing on behavioral investigations able to unveil acetaldehyde motivational effects and their pharmacological modulation in vivo. Similarly to alcohol, rats spontaneously drink acetaldehyde, whose presence is detected in the brain following chronic self-administration paradigm. Acetaldehyd…

Punishment (psychology)Stremedia_common.quotation_subjectMini ReviewDopamineCognitive NeuroscienceAlcohol abuseAcetaldehydeOperant behavior03 medical and health scienceschemistry.chemical_compoundstressBehavioral Neuroscience0302 clinical medicineDopamineNeuroplasticitymedicineendocannabinoidsmedia_commonEndocannabinoidAcetaldehyde; Dopamine; Endocannabinoids; Operant behavior; Stress; Neuropsychology and Physiological Psychology; Cognitive Neuroscience; Behavioral NeuroscienceAddictionAcetaldehydeExtinction (psychology)medicine.diseaseEndocannabinoid system030227 psychiatryNeuropsychology and Physiological PsychologychemistryPsychologyNeuroscience030217 neurology & neurosurgerymedicine.drugNeuroscience
researchProduct

The CB1Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis

2012

The generation and specification of pyramidal neuron subpopulations during development relies on a complex network of transcription factors. The CB1cannabinoid receptor is the major molecular target of endocannabinoids and marijuana active compounds. This receptor has been shown to influence neural progenitor proliferation and axonal growth, but its involvement in neuronal differentiation and the functional impact in the adulthood caused by altering its signaling during brain development are not known. Here we show that the CB1receptor, by preventing Satb2 (special AT-rich binding protein 2)-mediated repression, increased Ctip2 (COUP-TF interacting protein 2) promoter activity, and Ctip2-po…

Pyramidal tractsCannabinoid receptorGeneral Neurosciencemedicine.medical_treatmentCellular differentiationBiologyMotor neuronEndocannabinoid systemArticleGlutamatergicmedicine.anatomical_structurenervous systemCorticospinal tractmedicinelipids (amino acids peptides and proteins)CannabinoidNeuroscienceThe Journal of Neuroscience
researchProduct

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

2010

The endocannabinoid system (ECS) plays a critical role in obesity development. The pharmacological blockade of cannabinoid receptor type 1 (CB(1)) has been shown to reduce body weight and to alleviate obesity-related metabolic disorders. An unsolved question is at which anatomical level CB(1) modulates energy balance and the mechanisms involved in its action. Here, we demonstrate that CB(1) receptors expressed in forebrain and sympathetic neurons play a key role in the pathophysiological development of diet-induced obesity. Conditional mutant mice lacking CB(1) expression in neurons known to control energy balance, but not in nonneuronal peripheral organs, displayed a lean phenotype and res…

Sympathetic Nervous SystemPhysiologymedicine.medical_treatmentHUMDISEASEFluorescent Antibody TechniqueBody TemperatureMice0302 clinical medicineReceptor Cannabinoid CB1Cannabinoid receptor type 1ReceptorIn Situ HybridizationMice Knockout0303 health sciencesReverse Transcriptase Polymerase Chain ReactionCB(1)ThermogenesisEndocannabinoid systemOBESITYCB1 knock outlipids (amino acids peptides and proteins)CB(1); CANNABINOID RECEPTOR; OBESITY; ENDOCANNABINOID SYSTEM; METABOLIC DISORDERSSignal Transductionmedicine.medical_specialtyforebrainImmunoblottingCitrate (si)-SynthaseIn situ hybridizationHyperphagiaBiologyDNA MitochondrialModels BiologicalENDOCANNABINOID SYSTEMMOLNEURONO03 medical and health sciencesProsencephalonLipid oxidationInternal medicineMETABOLIC DISORDERSmedicineAnimalsMolecular BiologyCANNABINOID RECEPTOR030304 developmental biologyAnalysis of VarianceX-Ray MicrotomographyCell Biologyendocannabinoidenergy balanceEndocrinologynervous systemsympathetic neuronsForebrainCannabinoidEnergy Metabolismendocannabinoid; forebrain; sympathetic neurons; energy balance; CB1 knock outNeuroscienceThermogenesis030217 neurology & neurosurgery
researchProduct

Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent syna…

2013

A major goal in current neuroscience is to understand the causal links connecting protein functions, neural activity, and behavior. The cannabinoid CB1 receptor is expressed in different neuronal subpopulations, and is engaged in fine-tuning excitatory and inhibitory neurotransmission. Studies using conditional knock-out mice revealed necessary roles of CB1 receptor expressed in dorsal telencephalic glutamatergic neurons in synaptic plasticity and behavior, but whether this expression is also sufficient for brain functions is still to be determined. We applied a genetic strategy to reconstitute full wild-type CB1 receptor functions exclusively in dorsal telencephalic glutamatergic neurons a…

TelencephalonCannabinoid receptorLightBlotting WesternHippocampusGlutamic AcidBiologyNeurotransmissionAnxietyReal-Time Polymerase Chain ReactionAmygdalaHippocampus03 medical and health sciencesGlutamatergicMice0302 clinical medicineReceptor Cannabinoid CB1medicineExcitatory Amino Acid AgonistsAnimalsFear conditioning030304 developmental biologyMice KnockoutNeurons0303 health sciencesKainic AcidNeuronal PlasticityBehavior AnimalGeneral NeuroscienceArticlesAmygdalaEndocannabinoid systemImmunohistochemistryElectrophysiological PhenomenaMice Inbred C57BLmedicine.anatomical_structurenervous systemSynaptic plasticitySynapsesRNAlipids (amino acids peptides and proteins)Neuroscience030217 neurology & neurosurgerypsychological phenomena and processesJournal of Neuroscience
researchProduct

Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol

2020

Abstract Background Endothelial dysfunction promotes atherogenesis, vascular inflammation, and thrombus formation. Reendothelialization after angioplasty is required in order to restore vascular function and to prevent stent thrombosis. The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a known modulator of inflammation. Earlier studies have demonstrated the relevance of this endocannabinoid in human pathophysiology during coronary artery disease and in murine experimental atherogenesis. However, evidence on the impact of 2-AG on endothelial cell function remains scarce. Methods Endothelial repair was studied in two treatment groups of wildtype mice following electrical denudation o…

biologyEndotheliumCell adhesion moleculebusiness.industry2-Arachidonoylglycerolmedicine.diseaseEndocannabinoid systemCell biologyMonoacylglycerol lipaseEndothelial stem cellchemistry.chemical_compoundmedicine.anatomical_structurechemistryE-selectinmedicinebiology.proteinEndothelial dysfunctionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Modulators of Endogenous Neuroprotection: Estrogen, Corticotropin-releasing Hormone and Endocannabinoids

2005

Age-associated neurodegenerative disorders are among the most challenging problems of our aging society. Alzheimer’s disease is affecting people with increasing frequency, since there is a clear relationship between the incidence of this detrimental disorder and age. Other neurodegenerative disorders, including Parkinson’s disease, stroke and amyotrophic lateral sclerosis, are also frequently observed in our aging society. For most of these diseases, no causal therapy has yet been identified. Many of the treatments given to patients that are affected by these disorders have different side effects, and therefore the search is on to identify novel molecular approaches that may lead to a more …

business.industrymedicine.drug_classCentral nervous systemEstrogen receptorDiseaseNeuroprotectionEndocannabinoid systemCorticotropin-releasing hormonemedicine.anatomical_structureEstrogenmedicinebusinessCAMP response element bindingNeuroscience
researchProduct

Tricks and Tracks in the Identification and Quantification of Endocannabinoids

2013

Abstract The endocannabinoid system serves pivotal roles in a diverse range of physiological and pathophysiological states, including behavior, pain, schizophrenia, obesity, Alzheimer disease, multiple sclerosis and cardiovascular disease. A number of endocannabinoids (eCBs) and their receptors have been characterised and identified in a plethora of biological matrices. The eCBs include N-arachidonoyl ethanolamine (anandamide), 2-arachidonoyl glycerol, 2-arachidonoyl glyceryl ether (noladin ether), O-arachidonoyl ethanolamine (virodhamine) and N-arachidonoyl dopamine. Advanced targeted mass spectrometry methods, particularly the selected reaction monitoring, has facilitated sensitive quanti…

chemistry.chemical_compoundVirodhamineChromatographyTargeted mass spectrometryChemistrySignalling moleculeslipids (amino acids peptides and proteins)Immunological diseasesExtraction methodsLipid matrixNeuroscienceEndocannabinoid systemSite of actioneLS
researchProduct

P4140Myeloid but not endothelial expression of the CB2 receptor promotes atherogenesis in the context of elevated levels of the endocannabinoid 2-ara…

2019

Abstract Background The endocannabinoid 2-arachidonoylglycerol (2-AG) is an inflammatory mediator and ligand to the cannabinoid receptors CB1 and CB2, which are expressed on myeloid and endothelial cells. 2-AG has recently been described to promote atherogenesis in ApoE-deficient mice. While the CB2 receptor has previously been considered to solely exert anti-inflammatory and atheroprotective effects, newer data have raised the notion, that CB2 might exert atherogenic effects in the context of elevated 2-AG plasma levels. In the present study, we investigated the atherogenic mechanisms of 2-AG and the role of the CB2 receptor on myeloid and endothelial cells in atherogenesis using cell-spec…

chemistry.chemical_compoundchemistryExpression (architecture)business.industry2-ArachidonoylglycerolCannabinoid receptor type 2MedicineContext (language use)Cardiology and Cardiovascular MedicinebusinessEndocannabinoid systemCell biologyEuropean Heart Journal
researchProduct

The Epigenetics of the Endocannabinoid System

2020

The endocannabinoid system (ES) is a cell-signalling system widely distributed in biological tissues that includes endogenous ligands, receptors, and biosynthetic and hydrolysing machineries. The impairment of the ES has been associated to several pathological conditions like behavioural, neurological, or metabolic disorders and infertility, suggesting that the modulation of this system may be critical for the maintenance of health status and disease treatment. Lifestyle and environmental factors can exert long-term effects on gene expression without any change in the nucleotide sequence of DNA, affecting health maintenance and influencing both disease load and resistance. This potentially …

endocannabinoids; endocannabinoid system; epigenetics; Δ9THC; DNA methylation; histone modifications; non coding RNA; reproduction; spermatozoaReviewDiseaseEnvironmentnon coding RNACatalysisEpigenesis Geneticlcsh:ChemistryreproductionInorganic ChemistryStress PhysiologicalΔ9THCspermatozoaGene expressionAnimalsHumansEpigeneticsendocannabinoidsendocannabinoid systemPhysical and Theoretical ChemistryReceptors Cannabinoidlcsh:QH301-705.5Molecular BiologySpectroscopyDNA methylationepigeneticsbiologyhistone modificationsOrganic ChemistryCannabinoid Receptor AgonistsGeneral MedicineNon-coding RNAEndocannabinoid systemComputer Science ApplicationsCell biologyHistonelcsh:Biology (General)lcsh:QD1-999DNA methylationδ<sup>9</sup>thcbiology.proteinInternational Journal of Molecular Sciences
researchProduct